ClinicalTrials.govpublic full text
The Clinical Application of Chimeric Antigen Receptor T Cells in the Treatment of CD19 Positive Recurrent Refractory B Cell-derived Hematological Malignancies
b acute lymphoblastic leukemia, mantle cell lymphoma, follicular lymphoma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 287558
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.